OAAB05730
antibody from Aviva Systems Biology
Targeting: KXD1
BORCS4, C19orf50, FLJ25480, KXDL, MGC2749
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- OAAB05730 - Provider product page
- Provider
- Aviva Systems Biology
- Product name
- C19orf50 antibody - center region
- Antibody type
- Polyclonal
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 400ul
- Storage
- Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- C19orf50 Antibody (Center) western blot analysis in WiDr cell lysates (35ug/lane).This demonstrates the C19orf50 antibody detected the C19orf50 protein (arrow).
- Sample type
- WiDr cell line lysates
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Western blot analysis of C19orf50 (arrow) using rabbit polyclonal C19orf50 Antibody (Center) either nontransfected (Lane 1) or lysates transiently transfected transfected (Lane 2) with the C19orf50 gene.
- Sample type
- lysatestransiently transfected with the C19orf50 gene.
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- C19orf50 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the C19orf50 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.
- Sample type
- human lung carcinoma
- Primary Ab dilution
- 1.0 µg/mL
- Protocol
- Protocol